Innovative drug infusion technology for laboratory animals.

Japanese English
insidescientific e-book insidescientific insidescientific qanda
SMP-310R SMP-200 null null null null null null null null

News

  • News101 discreet infusion flow-rates and programmable infusions protocols (simple and complex)? Start all pumps simultaneously after recovery. Program starts and stops. Wondering how you would program this? Contact Primetech and ask us to have access to iPRECIO IMS-310R Group Profile or infusion < click here >. iPRECIO minipumps are the only programmable refillable and implantable drug delivery devices on the market.

    May 14, 2020

  • EventLooking to be inspired? “Dreams and Perseverance” Prof Robert Langer -https://lnkd.in/fEANB9w. Co-organizer of US-JAPAN SYMPOSIUM ON DRUG DELIVERY SYSTEMS. You can also join him for a chat, COVID-19: A chat with Bob Langer on vaccines, nanotech & the future of healthcare. Details are here, https://us02web.zoom.us/webinar/register/2215869257189/WN_HISlJAjlTuu8yF2YC_P4VQ - #nanotech #the_future_of_healthcare hashtag #drugdelivery #drugdiscovery

    April 20, 2020

  • News101 discreet infusion flow-rates and programmable infusions protocols (simple and complex)? Wondering how you would program this? Contact Primetech and ask us to have access to iPRECIO IMS-310R Group Profile or infusion < click here >. iPRECIO minipumps are the only programmable refillable and implantable drug delivery devices on the market.

    April 8, 2020

  • NewsImportant SMP-310R Product News.
    0 to 10ul/hr pumps now available. For CE version : from SN 9X9001 and for FCC and IC from SN 9Y0001. Quick Comparison < here > and Summary 310R < here >.

    January 31, 2020

  • NewsiPRECIO® for Mouse or larger – New Publication “Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism” Excerpt - By using an intracerebral infusion system equipped with implantable, programmable, and refillable pumps, we show herein that continuous intrastriatal administration of memantine (MMT), which is a non-competitive N-methyl-D-aspartate receptor antagonist, attenuates levodopa-induced dyskinesias and parkinsonian signs in 6-hydroxydopamine-lesioned hemiparkinsonian mice that received daily levodopa treatment.

    January 24, 2020

DMP-100

Our Mission with
iPRECIO® Product Portfolio:


Make it as easy as possible to evaluate efficacy of molecules/agents in different animal models and species.

Make the results as relevant as possible to the clinic. (Exposure profile, quantitative pharmacology, untethered free moving (stress free, group housing (socialization), ..…)


The use of iPRECIO® pumps will have a positive impact on experimental conditions and the relevance of results achieved. Initial costs maybe higher but in the long run the use of the pump could be cost saving in the context of the whole compound development.

Webinar: Gold Standard Physiological Measurements and Novel Drug Delivery Methods(Nov-2015)

Page top